lobbying_activities: 3011089

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3011089	c4288008-e13a-4f59-83c7-8d42de0d8fa7	Q2	WINNING STRATEGIES WASHINGTON	50796	KALEO	2023	second_quarter	PHA	Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2023-07-18T15:13:15-04:00